Biological and behavioral patterns of post-stroke depression in rats

Canadian Journal of Neurological Sciences

Volumn 45, Issue 4, 2018, Pages 451-461

  Ifergane, Gal ^a   Boyko, Matthew ^a   Frank, Dmitri ^a   Shiyntum, Honore N ^b   Grinshpun, Julia ^a   Kuts, Ruslan ^a   Geva, Amir B ^a   Kaplan, Zeev ^a   Zeldetz, Vladimir ^c   Cohen, Hagit ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b OLES HONCHAR DNIPRO NATIONAL UNIVERSITY   (Ukraine)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Animal model; Brain derived neurotrophic factor (BDNF); Middle cerebral artery occlusion (MCAO); Post stroke depression (PSD)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PROTEIN; SUCROSE;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AVOIDANCE BEHAVIOR; BEHAVIOR; BIOLOGICAL FUNCTIONS; CLINICAL EVALUATION; CONDITIONED AVOIDANCE RESPONSE TEST; CONTROLLED STUDY; DENTATE GYRUS; DISEASE DURATION; DOWN REGULATION; ESCAPE BEHAVIOR; EXPLORATORY BEHAVIOR; FORCED SWIM TEST; FRONTAL CORTEX; FUZZY SYSTEM; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HYPOTHALAMUS; IMMOBILITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL PLASTICITY; NONHUMAN; POST-STROKE DEPRESSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN EXPRESSION LEVEL; RAT; REVIEW; SHAM PROCEDURE; SUCROSE PREFERENCE TEST; TWO WAY SHUTTLE AVOIDANCE TASK; ANIMAL; BRAIN; BRAIN INFARCTION; CEREBRAL ARTERY DISEASE; CLUSTER ANALYSIS; COMPLICATION; DEPRESSION; DISEASE MODEL; FOOD PREFERENCE; METABOLISM; NEUROLOGIC EXAMINATION; NONPARAMETRIC TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT; SWIMMING;

ANIMALS; AVOIDANCE LEARNING; BRAIN; BRAIN INFARCTION; BRAIN-DERIVED NEUROTROPHIC FACTOR; CLUSTER ANALYSIS; DEPRESSION; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FOOD PREFERENCES; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROLOGIC EXAMINATION; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; SUCROSE; SWIMMING;

EID: 85050974637     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/cjn.2017.302     Document Type: Review

References (65)

1. Hyman C, Hofer M, Barde YA, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 1991; 350:230-2.
2. McAllister AK. Subplate neurons: a missing link among neurotrophins, activity, and ocular dominance plasticity? Proc Natl Acad Sci U S A. 1999;96:13600-2.
3. Shimada A, Mason CA, Morrison ME. TrkB signaling modulates spine density and morphology independent of dendrite structure in cultured neonatal Purkinje cells. Neuroscience. 1998;18:8559-70.
4. Solomon Z, Shklar R, Mikulincer M. Frontline treatment of combat stress reaction: a 20-year longitudinal evaluation study. Am J Psychiatry. 2005;162:2309-14.
5. Yacoubian TA, Lo DC. Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth. Nat Neurosci. 2000; 3:342-9.
6. Rutherford LC, Nelson SB, Turrigiano GG. BDNF has opposite effects on the quantal amplitude of pyramidal neuron and interneuron excitatory synapses. Neuron. 1998;21:521-30.
7. Seil FJ, Drake-Baumann R. TrkB receptor ligands promote activitydependent inhibitory synaptogenesis. Neuroscience. 2000;20: 5367-73.
8. Vicario-Abejon C, Collin C, McKay RD, Segal M. Neurotrophins induce formation of functional excitatory and inhibitory synapses between cultured hippocampal neurons. Neuroscience. 1998;18:7256-71.
9. Comelli MC, Seren MS, Guidolin D, et al. Photochemical stroke and brain-derived neurotrophic factor (BDNF) mRNA expression. Neuroreport. 1992;3:473-6.
10. Kokaia Z, Andsberg G, Yan Q, Lindvall O. Rapid alterations of BDNF protein levels in the rat brain after focal ischemia: evidence for increased synthesis and anterograde axonal transport. Exp Neurol. 1998;154:289-301.
11. Kokaia Z, Zhao Q, Kokaia M, et al. Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage. Exp Neurol. 1995;136:73-88.
12. Madinier A, Bertrand N, Mossiat C, et al. Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One. 2009;4:e8101.
13. Sulejczak D, Ziemlinska E, Czarkowska-Bauch J, Nosecka E, Strzalkowski R, Skup M. Focal photothrombotic lesion of the rat motor cortex increases BDNF levels in motor-sensory cortical areas not accompanied by recovery of forelimb motor skills. Neurotrauma. 2007;24:1362-77.
14. Chen J, Zhang C, Jiang H, et al. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. Cereb Blood Flow Metab. 2005;25:281-90.
15. Yanamoto H, Nagata I, Sakata M, et al. Infarct tolerance induced by intra-cerebral infusion of recombinant brain-derived neurotrophic factor. Brain Res. 2000;859:240-8.
16. Nakao N, Kokaia Z, Odin P, Lindvall O. Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons. Exp Neurol. 1995;131:1-10.
17. Petersen AA, Larsen KE, Behr GG, et al. Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death. Brain Res Bull. 2001;56:331-5.
18. Shimohama S, Tamura Y, Akaike A, et al. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons. Neurosci Lett. 1993;164:55-8.
19. Schabitz W, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke. 2000;31:2212-17.
20. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients: a three year longitudinal study. Stroke. 1993;24:976-82.
21. Eastwood MR, Rifat SL, Nobbs H, Ruderman J. Mood disorder following cerebrovascular accident. Br J Psychiatry. 1989;154: 195-200.
22. Robinson R, Bolduc P, Price T. Two-year longitudinal study of poststroke mood disorders: diagnosis and outcome at one and two years. Stroke. 1987;18:837-43.
23. Duman R. Synaptic plasticity and mood disorders. Mol Psychiatry. 2002;7:29-34.
24. Duman R. Depression: a case of neuronal life and death? Biol Psychiatry. 2004;56:140-5.
25. Manji H, Drevets W, Charney D. The cellular neurobiology of depression. Nat Med. 2001;7:541-7.
26. Boyko M, Zlotnik A, Gruenbaum BF, et al. An experimental model of focal ischemia using an internal carotid artery approach. Neurosci Methods. 2010;193:246-53.
27. Longa Z, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84-91.
28. Dittmar M, Spruss T, Schuierer G, Horn M. External carotid artery territory ischemia impairs outcome in the endovascular filament model of middle cerebral artery occlusion in rats. Stroke. 2003;34:2252-7.
29. Boyko M, Ohayon S, Goldsmith T, et al. Morphological and neurobehavioral parallels in the rat model of stroke. Behav Brain Res. 2011;223(1):17-23.
30. Boyko M, Ohayon S, Goldsmith T, et al. Cell-free DNAFA marker to predict ischemic brain damage in a rat stroke experimental model. Neurosurg Anesthesiol. 2011;23:222-8.
31. Ohayon S, Boyko M, Saad A, et al. Cell-free DNA as a marker for prediction of brain damage in traumatic brain injury in rats. Neurotrauma. 2012;29:261-7.
32. Boyko M, Kutz R, Gruenbaum BF, et al. The influence of aging on poststroke depression using a rat model via middle cerebral artery occlusion. Cogn Affect Behav Neurosci. 2013;13(4):847-59.
33. Association AP. Diagnostic and statistical manual of mental disorders, 4th edn., text revised edn. Washington, DC: American Psychiatric Association; 2000.
34. Boyko M, Kutza R, Grinshpun G, et al. Establishment of an animal model of depression contagion. Behav Brain Res. 2015;281: 358-63.
35. Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978;48:379-91.
36. Boyko M, Azabb AN, Kutsa R, et al. The neuro-behavioral profile in rats after subarachnoid hemorrhage. Brain Res. 2013;1491: 109-16.
37. Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977;266:730.
38. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 5th edn. Elsevier Academic Press; 2005.
39. Berg A, Palomäki H, Lehtihalmes M, Lönnqvist J, KasteM. Poststroke depression: an 18-month follow-up. Stroke. 2003;34:138-43.
40. Bezdek JC, Castelaz PF. Prototype classification and feature selection with fuzzy sets. IEEE Trans Syst Man Cybern Syst. 1971;17:87-92.
41. Bezdek JC, Pal NR. Some new validity indexes of cluster validity. IEEE Trans Syst Man Cybern Syst. 1998;28(3):301-15.
42. Gath I, Geva AB. Fuzzy clustering for the estimation of the parameters of the components of mixtures of normal distributions. Pattern Recognit Lett. 1989;9:77-86.
43. Rezaee MR, Lelieveldt BPF, Reiber JHC. A new cluster validity for the fuzzy c-mean. Pattern Recognit Lett. 1998:237-46.
44. Cohen H, Zohar J, Matar MA, Kaplan Z, Geva AB. Unsupervised fuzzy clustering analysis supports behavioral cutoff criteria in an animal model of posttraumatic stress disorder. Biol Psychiatry. 2005;58:640-50.
45. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci. 2002;23:238-45.
46. Nestler EJ, Gould E, Manji H, et al. Preclinical models: status of basic research in depression. Biol Psychiatry. 2002;52:503-28.
47. Geva AB. Feature extraction and state identification in biomedical signals using hierarchical fuzzy clustering. Med Biol Eng Comput. 1998;36:608-14.
48. Geva AB. Hierarchical-fuzzy clustering of temporal-patterns and its application for time-series prediction. Pattern Recognit Lett. 1999;20:1519-32.
49. Geva AB, Pratt H. Unsupervised clustering of evoked potentials by waveform. Med Biol Eng Comput. 1994;32:543-50.
50. Kotila M, Numminen H,Waltimo O, KasteM. Depression after stroke: results of the FINNSTROKE Study. Stroke. 1998;29:368-72.
51. Ramasubbu R, Robinson R, Flint A, Kosier T, Price T. Functional impairment associated with acute poststroke depression: the Stroke Data Bank Study. J Neuropsychiatry Clin Neurosci. 1998;10:26-33.
52. Nibuya M, Morinobu S, Duman R. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Neuroscience. 1995;15:7539-47.
53. Kronenberg G, Gertz K, Heinz A, Endres M. Of mice and men: modelling post-stroke depression experimentally. Br J Pharmacol. 2014;171(20):4673-89.
54. Malberg J, Eisch A, Nestler E, Duman R. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Neuroscience. 2000;20:9104-10.
55. Schwartz JA, Speed NM, Brunberg JA, Brewer TL, Brown M, Greden JF. Depression in stroke rehabilitation. Biol Psychiatry. 1993;33:694-9.
56. Kauhanen M, Korpelainen JT, Hiltunen P, et al. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke. 1999;30:1875-80.
57. Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR. Association of depression with 10-year poststroke mortality. Am J Psychiatry. 1993;150:124-9.
58. Williams LS, Ghose SS, Swindle RW. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry. 2004;161:1090-5.
59. Jorgensen L, Engstad T, Jacobsen B. Higher incidence of falls in long-term stroke survivors than in population controls: depressive symptoms predict falls after stroke. Stroke. 2002; 33:542-7.
60. Paolucci S, Antonucci G, Grasso MG, et al. Post-stroke depression, antidepressant treatment and rehabilitation results. A casecontrol study. Cerebrovasc Dis. 2001;12:264-71.
61. Zhou Z, Lu T, Xu G, et al. Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism. Clin Chem Lab Med. 2011;49(2):185-9.
62. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke. 1994;25:1099-104.
63. Currier M, Murray G, Welch C. Electroconvulsive therapy for poststroke depressed geriatric patients. Neuropsychiatry Clin Neurosci. 1992;4:140-4.
64. Robinson RG, Lipsey JR, Pearlson GD. The occurrence and treatment of poststroke mood disorders. Compr Ther. 1984;10:19-24.
65. Wiart L, Petit H, Joseph PA,Mazaux JM, Barat M. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000;31:1829-32.